Rekha Khandia – författare

This book offers a comprehensive exploration of brain tumors, beginning with a foundational understanding of their pathophysiology and extending through the latest advancements in diagnosis and treatment. The chapters examine the underlying mechanisms that drive the development and progression of brain tumors and present a detailed analysis of the incidence, distribution, and potential risk factors associated with brain tumors. The book explores the intricate relationship between brain tumors and visual disorders, and reviews the critical role of advanced imaging technologies in diagnosing brain tumors, evaluating the strengths and limitations of various modalities such as MRI and PET scans. Additionally, the book evaluates the effectiveness and precision of radiosurgery in targeting brain tumors, discussing its benefits and challenges in the context of non-invasive cancer treatment. The chapters also introduce us to antisense oligonucleotides as a novel therapeutic strategy, outlining their mechanism of action and potential to silence cancer-driving genes. The book highlights the latest developments in nanotechnology for brain tumor diagnosis, emphasizing the use of nanomaterials to enhance imaging quality and specificity.Key Features:Provides a thorough exploration of brain tumors, from basic pathophysiology to advanced treatment optionsPresents detailed analyses of the incidence, distribution, and potential risk factors associated with brain tumorsDiscusses the critical role of imaging technologies, including MRI and PET scans, in the diagnosis of brain tumorsIntroduces novel therapeutic strategies such as radiosurgery and antisense oligonucleotides for targeting brain tumorsExamines strategies to overcome the blood–brain barrier for effective drug deliveryToward the end, the book covers challenges of and strategies for delivering therapeutic agents across the blood–brain barrier and discusses phytochemicals in brain tumor treatment. This book serves as a useful source for researchers and students in oncology and neuroscience.